SCOTT FRICKE: Open Payments
NPI 1194338806 · SALIDA, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$170 in 7 payments from 4 companies in 2025. Trend: 2023 $2,321 · 2024 $1,828 · 2025 $170
Food & beverage: $170
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 3 | $76 |
| Alkermes, Inc. | 2 | $42 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
Products named: Qelbree, ARISTADA, CAPLYTA, REXULTI.
Industry payments across CO — which companies pay providers there.
